Business Context and Reporting Period
This Form 8-K is a current report filed by NanoVibronix, Inc. (trading symbol: NAOV) on August 30, 2022, with the report signed on September 2, 2022. The filing addresses a critical corporate governance event regarding the company's listing status on the Nasdaq Capital Market. Note: The request metadata references "Envue Medical, Inc.," but the filing text explicitly identifies the registrant as NanoVibronix, Inc.
Key Financial Metrics
This filing is a notice of a listing deficiency and does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The filing text does not provide a clear value for any financial metrics.
Material Changes
The material change reported is the receipt of a formal notice from the Nasdaq Listing Qualifications Staff indicating that the Company's securities are subject to delisting. This action is due to the Company's continued non-compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a). The Company failed to regain compliance by the August 29, 2022 deadline, which concluded a 180-calendar day grace period that began on March 1, 2022.
Outlook, Risks, and Management Commentary
- Management Action: The Company intends to timely request a hearing before the Nasdaq Hearings Panel. This request will stay any further delisting action by Nasdaq pending the Panel's decision and any potential extensions granted.
- Risk: The primary risk is the potential delisting of the Company's common stock from the Nasdaq Capital Market if compliance is not achieved or if the hearing does not result in a favorable outcome.
- Unusual Items: The filing references a press release issued on September 2, 2022, which is attached as Exhibit 99.1.
Investor Verification Checklist
- Verify the current trading status of NAOV on the Nasdaq Capital Market.
- Confirm the date and outcome of the hearing before the Nasdaq Hearings Panel.
- Review the press release dated September 2, 2022 (Exhibit 99.1) for additional details on the Company's plan to regain compliance.
- Monitor subsequent filings for updates on the minimum bid price compliance status.